Interest in Electronic Applications for Patients With Glaucoma (GlaucomaApp)
June 17, 2019 updated by: Jonathon Myers, Wills Eye
Interest of Patients and Their Caregivers in A Smartphone- and Tablet-Based Application for Patients With Glaucoma
To evaluation interest in use of smartphone- and tablet-based application (app) for participants with glaucoma, ocular hypertension, those at risk and their caregivers.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study is designed to determine the amount of interest in an educational application (app) on social media for glaucoma patients and their caregivers.
The purpose of this App is to enhance understanding of glaucoma by using short video tutorials. The App will include glaucoma eye drop medication reminders, a short video tutorial which aims to improve understanding of how visual field testing should be performed, how to administer eye drops and a feature that will enable participants to store and organize testing results using a mobile device.
Study Type
Observational
Enrollment (Actual)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19107
- Wills Eye Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Glaucoma patients or care givers
Description
Inclusion Criteria:
- Anyone affected by glaucoma
- Family and friends of someone with glaucoma
Exclusion Criteria:
- unable to complete survey
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Glaucoma Patients and Caregivers
Glaucoma patients and caregivers will complete a 20 item questionnaire providing demographic information, glaucoma eye drop compliance, interest in medication reminders, availability to smartphone, tablet and social media technology and interest in using a glaucoma application on social media.
|
Measuring interest in social media technology designed to educate glaucoma patients about disease, testing, and treatments with reminders for taking medications.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patients Owning Smartphone/Tablet Technology
Time Frame: 1 hour
|
Responses collected from participants about owning access to social media via smartphone or tablet technology obtained by completing a 20 item questionnaire.
|
1 hour
|
|
Patients Having Access to Social Media Via Smartphone or Tablet in the Home
Time Frame: 1 hour
|
Responses collected from participants about their personal access, through other members in the home, to social media via smartphone or tablet technology obtained by completing a 20 item questionnaire.
|
1 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Glaucoma Medication Compliance
Time Frame: 1 hour
|
Responses collected from participants about compliance to using their glaucoma drops as prescribed obtained by completing a 20 item questionnaire.
|
1 hour
|
|
Use of Medication Reminder
Time Frame: 1 hour
|
Responses collected from participants about use of medication reminders for their glaucoma drops obtained by completing a 20 item questionnaire.
|
1 hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jonathan S Myers, MD, Wills Eye Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2015
Primary Completion (Actual)
October 1, 2016
Study Completion (Actual)
October 1, 2016
Study Registration Dates
First Submitted
August 6, 2015
First Submitted That Met QC Criteria
January 19, 2016
First Posted (Estimate)
January 20, 2016
Study Record Updates
Last Update Posted (Actual)
August 5, 2019
Last Update Submitted That Met QC Criteria
June 17, 2019
Last Verified
June 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14-413E
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.